Skip to main content

Table 3 Interventions and medications during the last four weeks of life

From: Patterns of paediatric end-of-life care: a chart review across different care settings in Switzerland

  Total
N = 149
(100%)
Cardiology
n = 19
(13%)
Neonatology
n = 57
(38%)
Neurology
n = 36
(24%)
Oncology
n = 37
(25%)
p-value
Interventions requiring anaesthesia n = 148a    n = 35a   
 Yes, n (%) 51 (34) 11 (58) 21 (37) 6 (17) 13 (35) 0.021b
Mechanical ventilation
 Yes, n (%) 94 (63) 14 (74) 55 (97) 15 (42) 10 (27) <  0.001b
ECMO
 Yes, n (%) 7 (5) 4 (21) 3 (5) 0 (0) 0 (0) <  0.001b
Presence of CAD n = 148a     n = 36a  
 Yes, n (%) 106 (72) 14 (74) 55 (97) 12 (33) 25 (69) <  0.001b
Enteral feeds via nasogastric or gastrostomy tube n = 148a    n = 35a   
 Yes, n (%) 114 (77) 17 (90) 51 (90) 33 (94) 13 (35) <  0.001b
Medication count in the last week of lifec n = 146a    n = 35a n = 35a  
Mdn, (range) 12 (1 - 46) 19 (3 - 45) 12 (1 - 34) 10 (3 - 39) 13 (4 - 46) 0.006b
Mean, (SD) 14 (9.15) 21 (11.73) 12 (7.02) 13 (8.82) 15 (9.69)
Pain medication n = 148a    n = 35a   
 Yes, n (%) 140 (95) 18 (95) 54 (95) 33 (94) 35 (95) 1.000b
Anxiolytic medication n = 145a    n = 35a n = 34a  
 Yes, n (%) 84 (58) 14 (74) 27 (47) 18 (51) 25 (74) 0.032b
Antiemetic medication n = 146a    n = 35a n = 35a  
 Yes, n (%) 25 (17) 2 (11) 0 (0) 0 (0) 23 (66) <  0.001b
  1. ECMO Extracorporeal membrane oxygenation, CAD Central access device, either venous or arterial
  2. aInformation was missing for some cases
  3. bAcross the four groups, based on likelihood ratio chi-square
  4. cIncludes both standing daily dosages and as-needed orders